Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Matrix metalloproteinases contribute to the regulation of chemokine expression and pulmonary inflammation in Cryptococcus infection.

Supasorn O, Sringkarin N, Srimanote P, Angkasekwinai P.

Clin Exp Immunol. 2016 Mar;183(3):431-40. doi: 10.1111/cei.12725. Epub 2015 Nov 24.

2.

Cryptococcus gattii infection dampens Th1 and Th17 responses by attenuating dendritic cell function and pulmonary chemokine expression in the immunocompetent hosts.

Angkasekwinai P, Sringkarin N, Supasorn O, Fungkrajai M, Wang YH, Chayakulkeeree M, Ngamskulrungroj P, Angkasekwinai N, Pattanapanyasat K.

Infect Immun. 2014 Sep;82(9):3880-90. doi: 10.1128/IAI.01773-14. Epub 2014 Jun 30.

3.
4.

Chemokine responses and accumulation of inflammatory cells in the lungs of mice infected with highly virulent Cryptococcus neoformans: effects of interleukin-12.

Kawakami K, Shibuya K, Qureshi MH, Zhang T, Koguchi Y, Tohyama M, Xie Q, Naoe S, Saito A.

FEMS Immunol Med Microbiol. 1999 Sep;25(4):391-402.

5.

Enhanced innate immune responsiveness to pulmonary Cryptococcus neoformans infection is associated with resistance to progressive infection.

Guillot L, Carroll SF, Homer R, Qureshi ST.

Infect Immun. 2008 Oct;76(10):4745-56. doi: 10.1128/IAI.00341-08. Epub 2008 Aug 4.

6.

Altered immune response differentially enhances susceptibility to Cryptococcus neoformans and Cryptococcus gattii infection in mice expressing the HIV-1 transgene.

Leongson K, Cousineau-Côté V, Goupil M, Aumont F, Sénéchal S, Gaboury L, Jolicoeur P, Kronstad JW, de Repentigny L.

Infect Immun. 2013 Apr;81(4):1100-13. doi: 10.1128/IAI.01339-12. Epub 2013 Jan 22.

7.

Influenza A Virus as a Predisposing Factor for Cryptococcosis.

Oliveira LVN, Costa MC, Magalhães TFF, Bastos RW, Santos PC, Carneiro HCS, Ribeiro NQ, Ferreira GF, Ribeiro LS, Gonçalves APF, Fagundes CT, Pascoal-Xavier MA, Djordjevic JT, Sorrell TC, Souza DG, Machado AMV, Santos DA.

Front Cell Infect Microbiol. 2017 Sep 26;7:419. doi: 10.3389/fcimb.2017.00419. eCollection 2017.

8.

Leukocyte recruitment during pulmonary Cryptococcus neoformans infection.

Huffnagle GB, Traynor TR, McDonald RA, Olszewski MA, Lindell DM, Herring AC, Toews GB.

Immunopharmacology. 2000 Jul 25;48(3):231-6. Review.

PMID:
10960662
9.

The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model.

Ngamskulrungroj P, Chang Y, Sionov E, Kwon-Chung KJ.

MBio. 2012 May 8;3(3). pii: e00103-12. doi: 10.1128/mBio.00103-12. Print 2012.

10.

Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.

Specht CA, Lee CK, Huang H, Tipper DJ, Shen ZT, Lodge JK, Leszyk J, Ostroff GR, Levitz SM.

MBio. 2015 Dec 22;6(6):e01905-15. doi: 10.1128/mBio.01905-15.

11.

Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.

Wozniak KL, Ravi S, Macias S, Young ML, Olszewski MA, Steele C, Wormley FL.

PLoS One. 2009 Sep 3;4(9):e6854. doi: 10.1371/journal.pone.0006854.

12.

The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection.

Olszewski MA, Huffnagle GB, McDonald RA, Lindell DM, Moore BB, Cook DN, Toews GB.

J Immunol. 2000 Dec 1;165(11):6429-36.

13.

Cryptococcus neoformans pulmonary granuloma formation is associated with matrix metalloproteinase-2 expression.

Majka SM, Kasimos J, Izzo L, Izzo AA.

Med Mycol. 2002 Jun;40(3):323-8.

PMID:
12146765
14.
15.

Histopathological study of murine pulmonary cryptococcosis induced by Cryptococcus gattii and Cryptococcus neoformans.

Okubo Y, Wakayama M, Ohno H, Yamamoto S, Tochigi N, Tanabe K, Kaneko Y, Yamagoe S, Umeyama T, Shinozaki M, Nemoto T, Nakayama H, Sasai D, Ishiwatari T, Shimodaira K, Yamamoto Y, Kamei K, Miyazaki Y, Shibuya K.

Jpn J Infect Dis. 2013;66(3):216-21.

16.
17.

IL-4 receptor-alpha-dependent control of Cryptococcus neoformans in the early phase of pulmonary infection.

Grahnert A, Richter T, Piehler D, Eschke M, Schulze B, Müller U, Protschka M, Köhler G, Sabat R, Brombacher F, Alber G.

PLoS One. 2014 Jan 27;9(1):e87341. doi: 10.1371/journal.pone.0087341. eCollection 2014.

18.

A dual role for TGF-beta1 in the control and persistence of fungal pneumonia.

Shao X, Rivera J, Niang R, Casadevall A, Goldman DL.

J Immunol. 2005 Nov 15;175(10):6757-63.

19.

Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection.

Hardison SE, Wozniak KL, Kolls JK, Wormley FL Jr.

Infect Immun. 2010 Dec;78(12):5341-51. doi: 10.1128/IAI.00845-10. Epub 2010 Oct 4.

20.

STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans.

Leopold Wager CM, Hole CR, Wozniak KL, Olszewski MA, Mueller M, Wormley FL Jr.

Infect Immun. 2015 Dec;83(12):4513-27. doi: 10.1128/IAI.00935-15. Epub 2015 Sep 8.

Supplemental Content

Support Center